Volume 92, Issue 7 pp. 1453-1457
Valvular and Structural Heart Diseases

First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis

Ulrich Schäfer MD

Corresponding Author

Ulrich Schäfer MD

Department of Cardiology, University Heart Center, Hamburg, Germany

Correspondence Schäfer Ulrich, MD, University Heart Center Hamburg, Martinistrasse 46, 20246 Hamburg, Germany. Email: [email protected]Search for more papers by this author
Daniel Kalbacher MD

Daniel Kalbacher MD

Department of Cardiology, University Heart Center, Hamburg, Germany

Search for more papers by this author
Lisa Voigtländer MD

Lisa Voigtländer MD

Department of Cardiology, University Heart Center, Hamburg, Germany

Search for more papers by this author
Lenard Conradi MD

Lenard Conradi MD

Department of Cardiac Surgery, University Heart Center, Hamburg, Germany

Search for more papers by this author
First published: 23 January 2018
Citations: 6

Abstract

With next-generation valves such as the ALLEGRA valve from NewValve Technologies (NVT), Hechingen Germany, there is a very likely treatment expansion for patients with aortic valve disease. Besides treatment of native valvular aortic stenosis with the ALLEGRA valve, the special implant mechanism seems to be an appealing concept for patients with degenerated surgical bioprostheses. We report the first case of a transfemoral implantation in small degenerated surgical bioprosthesis of a 76-year-old woman.

Conflict of interest

Ulrich Schäfer is a consultant to New Valve Technology, all other authors have nothing to disclose.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.